"Metabolic aspects" in inflammatory bowel diseases

Current Drug Delivery

Volumn 9, Issue 4, 2012, Pages 326-332

  Kaser, Arthur ^a   Tilg, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adipocytokines; Adiponectin; Autophagy; Leptin; Supported by the christian doppler research society; Xbp1

Indexed keywords

ADIPONECTIN; INFLIXIMAB; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; X BOX BINDING PROTEIN 1;

ABDOMINAL FAT; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATG16L1 GENE; AUTOPHAGY; CELL DIFFERENTIATION; CROHN DISEASE; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; EPITHELIUM CELL; FATTY ACID SYNTHESIS; GENE; HUMAN; LIPID METABOLISM; MESENTERIC FAT; MESENTERY; METABOLIC REGULATION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84863555608     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112801323044     Document Type: Article

References (65)

1. Tilg, H.; Moschen, A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol., 2006, 6, 772-783.
2. Desreumaux, P.; Ernst, O.; Geboes, K.; Gambiez, L.; Berrebi, D.; Müller-Alouf, H.; Hafraoui, S.; Emilie, D.; Ectors, N.; Peuchmaur, M.; Cortot, A.; Capron, M.; Auwerx, J.; Colombel, JF. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology, 1999, 117, 73-81.
3. Berg, A.H.; Combs, T.P.; Scherer, P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab., 2002, 13,84-89.
4. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
5. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., Matsuzawa, Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50, 2094-2099.
6. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100, 2473-2476.
7. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K., Kadowaki, T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med., 2007, 13, 332-339.
8. Tilg, H., Moschen, A.R. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin. Sci. (Lond), 2008, 114, 275-288.
9. Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K, Nagaretani, H., Kishida, K., Maeda, N., Nagasawa, A., Funahashi, T., Matsuzawa, Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 2004, 109, 2046-2049.
10. Wulster-Radcliffe, M.C., Ajuwon, K.M., Wang, J., Christian, J.A., Spurlock, M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun., 2004, 316, 924-929.
11. Wolf, A.M., Wolf, D., Rumpold, H., Enrich, B., Tilg, H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL- 1RA in human leukocytes. Biochem. Biophys. Res. Commun., 2004, 323, 630-635.
12. Sheehan, A.L., Warren, B.F., Gear, M.W., Shepherd, N.A. Fatwrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br. J. Surg., 1992, 79, 955-958.
13. Yamamoto, K., Kiyohara, T., Murayama, Y., Kihara, S., Okamoto, Y., Funahashi, T., Ito, T., Nezu, R., Tsutsui, S., Miyagawa, J.I., Tamura, S., Matsuzawa, Y., Shimomura, I., Shinomura, Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut, 2005, 54, 789-796.
14. Konrad, A., Lehrke, M., Schachinger, V., Seibold, F., Stark, R., Ochsenkühn, T., Parhofer, K.G., Göke, B., Broedl, U.C. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur. J. Gastroenterol. Hepatol., 2007, 19, 1070-1074.
15. Barbier, M., Vidal, H., Desreumaux, P., Dubuquoy, L., Bourreille, A., Colombel, J.F., Cherbut, C., Galmiche, J.P. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol. Clin. Biol., 2003, 27, 987-991.
16. Paul, G., Schäffler, A., Neumeier, M., Fürst, A., Bataillle, F., Buechler, C., Müller-Ladner, U., Schölmerich, J., Rogler, G., Herfarth, H. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm. Bowel. Dis., 2006, 12, 471-477.
17. Weigert, J., Obermeier, F., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Aslanidis, C., Rogler, G., Ott, C., Schäffler, A., Schölmerich, J., Buechler, C. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm. Bowel. Dis., 2010, 16, 630-637.
18. Fayad, R., Pini, M., Sennello, J.A., Cabay, R.J., Chan, L., Xu, A., Fantuzzi, G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology, 2007, 132, 601-614.
19. Nishihara, T., Matsuda, M., Araki, H., Oshima, K., Kihara, S., Funahashi, T., Shimomura, I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology, 2006, 131, 853-361.
20. Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., Leibowitz, M.D., Colombel, J.F., Auwerx, J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med., 2001, 193, 827-838.
21. Lewis, J.D., Lichtenstein, G.R., Deren, J.J., Sands, B.E., Hanauer, S.B., Katz, J.A., Lashner, B., Present, D.H., Chuai, S., Ellenberg, J.H., Nessel, L., Wu, G.D. Rosiglitazone for Ulcerative Colitis Study Group. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology, 2008, 134, 688-95.
22. La Cava, A., Matarese, G. The weight of leptin in immunity. Nat. Rev.Immunol., 2004, 4, 371-9.
23. Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., Feingold, K.R. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest., 1996, 97, 2152-7.
24. Matarese, G., Moschos, S., Mantzoros, C.S. Leptin in immunology. J. Immunol., 2005, 174, 3137-42.
25. Takahashi, N., Waelput, W., Guisez, Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J. Exp. Med., 1999, 189, 207-12.
26. Faggioni, R., Jones-Carson, J., Reed, D.A., Dinarello, C.A., Feingold, K.R., Grunfeld, C., Fantuzzi, G. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 2367-72.
27. Matarese, G., Di Giacom, A., Sanna, V., Lord, G.M., Howard, J.K. Di Tuoro, A., Bloom, S.R., Lechler, R.I., Zappacosta, S., Fontana, S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol., 2001, 166, 5909-16.
28. Siegmund, B., Sennello, J.A., Jones-Carson, J., Gamboni- Robertson, F., Lehr, H.A., Batra, A., Fedke, I, Zeitz, M., Fantuzzi, G. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut, 2004, 53, 965-72.
29. Siegmund, B., Lehr, H.A., Fantuzzi, G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology, 2002, 122, 2011-25.
30. Sitaraman, S., Liu, X. Charrier, L., Gu, L.H, Ziegler, T.R., Gewirtz, A., Merlin, D. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J. 2004, 18, 696-8.
31. Smedh, K., Olaison, G., Nyström P.O., Sjödahl R. Intraoperative enteroscopy in Crohn's disease. Br. J. Surg., 1993, 80, 8 97-900.
32. Parmentier-Decrucq, E., Duhamel, A., Ernst, O., Fermont, C., Louvet, A., Vernier-Massouille, G., Cortot, A., Colombel, J.F., Desreumaux, P., Peyrin-Biroulet, L. Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm, Bowel. Dis., 2009, 15, 1476-84.
33. Van Limbergen, J., Wilson, D.C., Satsangi, J. The Genetics of Crohn's Disease. Annu. Rev. Genom. Hum. Genet., 2009, 10, 89-116.
34. Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La, Vega, F.M., Briggs, J., Günther, S., Prescott, N.J., Onnie, C.M., Häsler, R., Sipos, B., Fölsch, U.R., Lengauer, T., Platzer, M., Mathew, C.G., Krawczak, M., Schreiber, S. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet., 2007, 39, 207-11.
35. Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., Kishi, C., Kc, W., Carrero, J.A., Hunt, S., Stone, C.D., Brunt, E.M., Xavier, R.J., Sleckman, B.P., Li, E., Mizushima, N., Stappenbeck, T.S., Virgin, H.W 4th. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature, 2008, 456, 259-63.
36. Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M.M., Datta, L.W., Shugart, Y.Y., Griffiths, A.M., Targan, S.R., Ippoliti, A.F., Bernard, E.J., Mei, L., Nicolae, D.L., Regueiro, M., Schumm, L.P., Steinhart, A.H., Rotter, J.I., Duerr, R.H., Cho, J.H., Daly, M.J., Brant, S.R. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet., 2007, 39, 596-604.
37. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007, 447, 661-78.
38. Parkes, M., Barrett, J.C., Prescott, N.J., Tremelling, M., Anderson, C.A., Fisher, S.A., Roberts, R.G., Nimmo, E.R., Cummings, F.R., Soars, D., Drummond, H., Lees, C.W., Khawaja, S.A., Bagnall, R., Burke, D.A., Todhunter, C.E., Ahmad, T., Onnie, C.M., McArdle, W., Strachan, D., Bethel, G., Bryan, C., Lewis, C.M., Deloukas, P., Forbes, A., Sanderson, J., Jewell, D.P., Satsangi, J. Mansfield, J.C; Wellcome Trust Case Control Consortium. Cardon, L., Mathew, C.G. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet., 2007, 39, 830-2.
39. McCarroll, S.A., Huett, A., Kuballa, P., Chilewski, S.D., Landry, A., Goyette, P., Zody, M.C., Hall, J.L., Brant, S.R., Cho, J.H, Duerr, R.H., Silverberg, M.S., Taylor, K.D., Rioux, J.D., Altshuler, D., Daly, M.J., Xavier, R.J. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet., 2008, 40, 1107-12.
40. Levine, B., Kroemer, G. Autophagy in the pathogenesis of disease. Cell, 2008, 132, 27-42.
41. Van Limbergen, J., Stevens, C., Nimmo, E.R., Wilson, D.C, Satsangi J. Autophagy: from basic science to clinical application. Mucosal Immunol., 2009, 2(4): 315-30.
42. Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451, 1069-75.
43. Huett, A., Xavier, R.J. Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases. Inflamm. Bowel Dis., 2010, 16, 152-74.
44. Garrett, W.S., Gordon, J.I., Glimcher, L.H. Homeostasis and inflammation in the intestine. Cell, 2010, 140, 859-70.
45. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., Lochs, H. Mucosal flora in inflammatory bowel disease. Gastroenterology, 2002, 122, 44-54.
46. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer, M.A., Swidsinski, A., Beaugerie, L., Colombel, J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 2004, 127, 412-21.
47. Lapaquette, P., Glasser, A.L., Huett, A., Xavier, R.J., Darfeuille-Michaud, A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol., 2010, 12, 99-113.
48. Travassos, L.H., Carneiro, L.A., Ramjeet, M., Hussey, S., Kim, Y.G, Magalhães, J.G, Yuan, L., Soares, F., Chea, E., Le Bourhis, L., Boneca, I.G., Allaoui, A., Jones, N.L, Nuñez, G., Girardin S.E., Philpott, D.J. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol., 2010, 11, 55-62.
49. Cooney, R., Baker, J, Brain, O., Danis, B., Pichulik, T., Allan, P., Ferguson, D.J., Campbell, B.J., Jewell, D., Simmons, A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med., 2010, 16, 90-7.
50. Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K, Cuervo, A.M., Czaja, M.J. Autophagy regulates lipid metabolism. Nature, 2009, 458, 1131-5.
51. Zechner, R., Madeo, F. Cell biology: Another way to get rid of fat. Nature, 2009, 458, 1118-9.
52. Zechner, R., Kienesberger, P.C., Haemmerle, G., Zimmermann, R., Lass, A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res., 2009, 50, 3-21.
53. Ron, D., Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol., 2007, 8, 519-29.
54. Todd, D.J., Lee, A.H., Glimcher, L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol., 2008, 8, 663-74.
55. Kaser, A., Lee, A.H., Franke, A., Glickman, J.N., Zeissig, S., Tilg, H., Nieuwenhuis, E.E., Higgins, D.E., Schreiber, S., Glimcher, L.H., Blumberg, RS. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell, 2008, 134, 743-56.
56. Barrett, J.C., Hansoul, S., Nicolae, D.L, Cho, J.H., Duerr, R.H., Rioux, J.D., Brant, S.R., Silverberg, M.S., Taylor, K.D., Barmada, M.M., Bitton, A., Dassopoulos, T., Datta, L.W., Green, T., Griffiths, A.M., Kistner, E.O., Murtha, M.T., Regueiro, M.D., Rotter, J.I., Schumm, L.P., Steinhart, A.H., Targan, S.R., Xavier, R. J.NIDDK IBD Genetics Consortium, Libioulle, C., Sandor, C., Lathrop, M., Belaiche, J., Dewit, O., Gut, I., Heath, S., Laukens, D., Mni M, Rutgeerts, P., Van Gossum, A, Zelenika, D., Franchimont, D., Hugot, J.P., de Vos, M., Vermeire, S., Louis, E. Belgian-French, IBD Consortium; Wellcome Trust Case Control Consortium, Cardon LR, Anderson CA, Drummond, H., Nimmo, E., Ahmad, T., Prescott, N.J., Onnie, C.M., Fisher, S.A., Marchini, J., Ghori, J., Bumpstead, S., Gwilliam, R, Tremelling, M., Deloukas, P., Mansfield, J., Jewell, D., Satsangi, J., Mathew, C.G., Parkes, M., Georges, M., Daly, M.J. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet., 2008, 40, 955-62.
57. McGovern, D.P., Gardet, A., Törkvist, L., Goyette, P., Essers, J., Taylor, K.D., Neale, B.M., Ong, R.T., Lagacé, C., Li, C., Green, T., Stevens, C.R., Beauchamp, C., Fleshner, P.R., Carlson, M., D'Amato, M., Halfvarson, J., Hibberd, M.L., Lördal, M., Padyukov, L., Andriulli, A., Colombo, E., Latiano, A., Palmieri, O., Bernard, E.J., Deslandres, C., Hommes, D.W., de Jong, D.J., Stokkers, P.C., Weersma, R.K. NIDDK IBD Genetics Consortium, Sharma, Y,. Silverberg, M.S., Cho, J.H., Wu, J., Roeder, K., Brant, S.R., Schumm, L.P., Duerr R.H., Dubinsky, M.C., Glazer, N.L., Haritunians, T., Ippoliti, A., Melmed G.Y., Siscovick, D.S, Vasiliauskas, E.A., Targan, S.R., Annese, V., Wijmenga, C, Pettersson, S., Rotter, J.I., Xavier, R.J., Daly, M.J., Rioux, J.D., Seielstad, M. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet., 2010, 42, 332-337.
58. Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, G., Cuervo, A.M., Brown RH, Glimcher LH. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev., 2009, 23, 2294-306.
59. Ogata, M., Hino, S., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., Shiosaka, S., Hammarback, J.A., Urano, F., Imaizumi, K. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell Biol., 2006, 26, 9220-31.
60. Heazlewood, C.K., Cook, M.C., Eri, R, Price GR, Tauro SB, Taupin, D, Thornton, D.J., Png, C.W., Crockford, T.L., Cornall, R.J., Adams, R., Kato, M., Nelms, K.A., Hong, N.A., Florin, T.H, Goodnow, C.C., McGuckin, M.A. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med., 2008, 5, e54.
61. Kouroku, Y., Fujita, E., Tanida, I., Ueno, T., Isoai, A., Kumagai, H., Ogawa, S., Kaufman, R.J., Kominami, E., Momoi, T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamineinduced LC3 conversion, an essential step for autophagy formation. Cell Death Differ., 2007, 14, 230-9.
62. Fujita, E., Kouroku, Y., Isoai, A., Kumagai, H., Misutani, A., Matsuda, C., Hayashi, Y.K., Momoi, T. Two endoplasmic reticulumassociated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). Hum. Mol. Genet., 2007, 16, 618-29.
63. Lee, A.H., Scapa, E.F., Cohen, D.E., Glimcher, L.H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science, 2008, 320, 1492-6.
64. Sha, H., He, Y., Chen, H., Wang, C., Zenno, A., Shi, H., Yang, X., Zhang, X., Qi, L. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab., 2009, 9, 556-64.
65. Farmer, S.R. Transcriptional control of adipocyte formation. Cell Metab., 2006, 4,263-73.